Welcome to Sun-shine chemical
+86-17702719238 sales@sun-shinechem.com

Products

Catalog NoChemical NameCAS NumberPurityChemical Structure
112194AMG-510 racemate2252403-56-698% Min.
AMG-510 is a potent KRAS G12C covalent inhibitor. AMG-510 selectively targets the KRA
112191Aprocitentan1103522-45-798% Min.
Aprocitentan is an orally active, dual endothelin (ET) receptor antagonist developed
6111903Aramchol246529-22-698% Min.
Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With
513191Acibenzolar acid35272-27-696% Min.
benzo[d][1,2,3]thiadiazole-7-carboxylic acid,Acibenzolar acid,CGA 210 007
193291AR-C155858496791-37-8>98%
AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that b
193288ACT-7094781838651-58-3>98%
ACT-709478 is a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate
193287A18742064292-12-0>98%
A1874 is a nutlin-based and BRD4-degrading PROTAC which induces BRD4 degradation in c
193254AZD95671893415-00-3>98%
AZD9567 is an oral differentiated non-steroidal selective glucocorticoid receptor mod
193222AZ14952196204-23-4>98%
AZ1495 is a potent and selective IRAK4 inhibitor.
193208ATR-101 HCl133825-81-7>98%
ATR-101, also known as PD-132301 (a free base) or PD-132301-2 (a HCl salt), is in cli
193192ARN-32361613710-01-2>98%
ARN-3236 is potent, orally active and selective SIK2 inhibitor. ARN-3236 inhibited th
193134ARN 0771373625-34-3>98%
ARN 077 is a potent and selective N-acylethanolamine acid amidase (NAAA) inhibitor wi
193125Aleglitazar475479-34-6>98%
Aleglitazar, also known as RG-1439 or RO-0728804, is a peroxisome proliferator-activa
19382Alvimopan156053-89-3>98%
Alvimopan, also known as HSDB-7704 and LY246736, is a drug which behaves as a periphe
19381Abrocitinib1622902-68-4>98%
Abrocitinib, Bulk in stock, contact us by email for the quotation. Kg scale intermedi
19372AA26-91312782-34-5>98%
AA26-9 is a potent and broad-spectrum serine hydrolase inhibitor. AA26-9-inhibited en
19365AZD-02842101291-07-8>98%
AZD-0284 is a potent, selective, inverse agonist of the nuclear receptor RORγ for th
19363AZ304942507-42-8>98%
AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type B
19356AZ876898800-26-5>98%
AZ876, also known as AZ-876, is a liver X receptor agonist. AZ876 protects against pa
19316AGN-190299118292-41-4>98%
Tazarotene is a retinoid prodrug which is converted to its active form, the cognate c
19315AM281202463-68-1>98%
AM281 is a synthetic cannabinoid CB1 receptor antagonist.
19312ASP9521 1126084-37-4>98%
ASP9521 is a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid d
192275AZD03642097416-76-5>98%
AZD0364 is an ERK1 and/or ERK2 kinase for the treatment of cancer. ERK1 and ERK2 kina
192212ATF6-activator-147 393121-74-9>98%
ATF6-activator-147 is an ATF6 simulator which acts as a prodrug that preferentially t
192156AZD1152722543-31-9>98%
AZD1152 is a pro-drug of Barasertib-hQPA, which is a highly selective Aurora B inhibi
191287AZD32292248003-60-1>98%
AZD3229 is a potent pan-KIT mutant inhibitor for the treatment of gastrointestinal st
191251AM095 sodium1345614-59-6>98%
AM095 is a potent LPA1 receptor antagonist because it inhibited GTPγS binding to Chi
191212AZD4573 free base2057509-72-3>98%
AZD-4573 is a selective, short-acting inhibitor of the serine/threonine cyclin-depend
191146AR-9281913548-29-5>98%
AR-9281 is a soluble epoxide hydrolase (s-EH) inhibitor potentially for the treatment
191112ARRY-797 (ARRY-371797)1036404-17-799% Min.
ARRY-797 is an oral, selective p38 mitogen-activated protein kinase inhibitor. ARRY-7